Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis von Krez, A., Lane, J., Heilbronner, A., Park-Min, K.-H., Kaneko, K., Pannellini, T., Mintz, D., Hansen, D., McMahon, D.J., Kirou, K.A., Roboz, G., Desai, P., Bockman, R.S., Stein, E.M.

Volltext

A surge in anti-dsDNA titer predicts a severe lupus flare within six months von Pan, N, Amigues, I, Lyman, S, Duculan, R, Aziz, F, Crow, MK, Kirou, KA

Volltext

Age- and gender-specific modulation of serum osteopontin and interferon-α by osteopontin genotype in systemic lupus erythematosus von Kariuki, S N, Moore, J G, Kirou, K A, Crow, M K, Utset, T O, Niewold, T B

Volltext

Feasibility of Patient-Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive tests in systemic lupus erythematosus outpatients von Kasturi, S, Burket, J C, Berman, J R, Kirou, K A, Levine, A B, Sammaritano, L R, Mandl, L A

Volltext

Trial of Anifrolumab in Active Systemic Lupus Erythematosus von Morand, Eric F, Furie, Richard, Tanaka, Yoshiya, Bruce, Ian N, Askanase, Anca D, Richez, Christophe, Bae, Sang-Cheol, Brohawn, Philip Z, Pineda, Lilia, Berglind, Anna, Tummala, Raj

Volltext

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis von Stone, John H, Merkel, Peter A, Spiera, Robert, Seo, Philip, Langford, Carol A, Hoffman, Gary S, Kallenberg, Cees G.M, St. Clair, E. William, Turkiewicz, Anthony, Tchao, Nadia K, Webber, Lisa, Ding, Linna, Sejismundo, Lourdes P, Mieras, Kathleen, Weitzenkamp, David, Ikle, David, Seyfert-Margolis, Vicki, Mueller, Mark, Brunetta, Paul, Allen, Nancy B, Fervenza, Fernando C, Geetha, Duvuru, Keogh, Karina A, Kissin, Eugene Y, Monach, Paul A, Peikert, Tobias, Stegeman, Coen, Ytterberg, Steven R, Specks, Ulrich

Volltext

Induction of Fas Ligand-Mediated Apoptosis by Interferon-α von Kirou, Kyriakos A., Krishna, Radha, Maria, Vakkalanka, Butler, J., Crow, Mary K.

Volltext

New Pieces to the SLE Cytokine Puzzle von Kirou, Kyriakos A., Crow, Mary K.

Volltext

Regulation of CD40 ligand expression in systemic lupus erythematosus von Crow, Mary K, Kirou, Kyriakos A

Volltext

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial von Spiera, Robert F, Gordon, Jessica K, Mersten, Jamie N, Magro, Cynthia M, Mehta, Mansi, Wildman, Horatio F, Kloiber, Stacey, Kirou, Kyriakos A, Lyman, Stephen, Crow, Mary K

Volltext

Sarcoidosis presenting with large vessel vasculitis and osteosclerosis-related bone and joint pain von KIROU, K. A, BATEMAN, H. E, BANSAL, M, SCHNEIDER, R, FANTINI, G. A, PAGET, S. A

Volltext

Enhanced Rho‐Associated Protein Kinase Activation in Patients With Systemic Lupus Erythematosus von Isgro, Josephine, Gupta, Sanjay, Jacek, Elzbieta, Pavri, Tanya, Duculan, Roland, Kim, Mimi, Kirou, Kyriakos A., Salmon, Jane E., Pernis, Alessandra B.

Volltext

Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera von Vakkalanka, Radha Krishna, Woo, Caroline, Kirou, Kyriakos A., Koshy, Mary, Berger, Douglas, Crow, Mary K.

Volltext

Microarray Analysis of Interferon-regulated Genes in SLE von Crow, Mary K., Kirou, Kyriakos A., Wohlgemuth, Jay

Volltext

Interferon-α in systemic lupus erythematosus von Crow, Mary K, Kirou, Kyriakos A

Volltext

Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases von Goules, Andreas, Tzioufas, Athanasios G., Manousakis, Menelaos N., Kirou, Kyriakos A., Crow, Mary K., Routsias, John G.

Volltext

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon   monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind rand... von Merrill, J. T., Wallace, D. J., Petri, M., Kirou, K. A., Yao, Y., White, W. I., Robbie, G., Levin, R., Berney, S. M., Chindalore, V., Olsen, N., Richman, L., Le, C., Jallal, B., White, B.

Volltext

Cytokine-mediated regulation of activating and inhibitory Fcγ receptors in human monocytes von Liu, Yi, Masuda, Emi, Blank, Marissa C., Kirou, Kyriakos A., Gao, Xiaoni, Park, Mee‐Soon, Pricop, Luminita

Volltext

The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis von Thurlings, R M, Boumans, M, Tekstra, J, Vos, K, van Westing, D M, van Baarsen, L G, Bos, C, Kirou, K A, Gerlag, D M, Crow, M K, Verweij, C L, Tak, P P

Volltext

Age- and gender-specific modulation of serum osteopontin and interferon-[alpha] by osteopontin genotype in systemic lupus erythematosus von Kariuki, S N, Moore, J G, Kirou, K A, Crow, M K, Utset, T O, Niewold, T B

Volltext